Current evidence and future perspectives on pharmacological treatment of calcific aortic valve stenosis

M Donato, N Ferri, MG Lupo, E Faggin… - International journal of …, 2020 - mdpi.com
Calcific aortic valve stenosis (CAVS), the most common heart valve disease, is characterized
by the slow progressive fibro-calcific remodeling of the valve leaflets, leading to progressive …

Determinants and treatments of heart failure after transcatheter aortic valve implantation: moving up a notch

K Matsushita, B Marchandot, A Trimaille… - ESC Heart …, 2023 - Wiley Online Library
Transcatheter aortic valve implantation (TAVI) has become an alternative to surgical aortic
valve replacement for patients with symptomatic severe aortic stenosis in elderly and …

Ramipril in high-risk patients with COVID-19

IJ Amat-Santos, S Santos-Martinez… - Journal of the American …, 2020 - jacc.org
Abstract Background Coronavirus disease-2019 (COVID-19) is caused by severe acute
respiratory-syndrome coronavirus-2 that interfaces with the renin-angiotensin-aldosterone …

Determinants and impact of heart failure readmission following transcatheter aortic valve replacement

V Auffret, A Bakhti, G Leurent, M Bedossa… - Circulation …, 2020 - Am Heart Assoc
Background: Heart failure (HF) readmission is common post–transcatheter aortic valve
replacement (TAVR). Nonetheless, limited data are available regarding its predictors and …

Renin‐angiotensin system blockade in aortic stenosis: implications before and after aortic valve replacement

SS Goel, NS Kleiman, WA Zoghbi… - Journal of the …, 2020 - Am Heart Assoc
Aortic stenosis (AS) is a common valvular heart disease in the aging population that is
characterized by a variable period of asymptomatic phase before development of symptoms …

Transcatheter aortic valve replacement in heart failure

PB Parikh, M Mack, GW Stone, SD Anker… - European Journal of …, 2024 - Wiley Online Library
Patients with severe aortic stenosis (AS) may develop heart failure (HF), the presence of
which has traditionally been deemed as a final stage in AS progression with poor outcomes …

Management of patients with combined arterial hypertension and aortic valve stenosis: a consensus document from the Council on Hypertension and Council on …

C Mancusi, G de Simone, J Brguljan Hitij… - European Heart …, 2021 - academic.oup.com
Aortic valve stenosis (AS) is the third most common cardiovascular disease. The prevalence
of both AS and arterial hypertension increases with age, and the conditions therefore often …

Sex differences in aortic stenosis: from pathophysiology to treatment

S Saeed, MR Dweck, J Chambers - Expert review of cardiovascular …, 2020 - Taylor & Francis
Introduction: In aortic stenosis (AS), there are clear sex differences in clinical presentation,
left ventricular (LV) response to pressure overload, and pathophysiology of valvular …

Arterial hypertension in aortic valve stenosis: a critical update

C Basile, I Fucile, M Lembo, MV Manzi, F Ilardi… - Journal of Clinical …, 2021 - mdpi.com
Aortic stenosis (AS) is a very common valve disease and is associated with high mortality
once it becomes symptomatic. Arterial hypertension (HT) has a high prevalence among …

Hypertension in aortic stenosis: a focused review and recommendations for clinical practice

S Saeed, F Scalise, JB Chambers… - Journal of …, 2020 - journals.lww.com
In patients with aortic stenosis, the presence of hypertension negatively affects the
hemodynamic severity of the stenosis, and worsens adverse left ventricular remodeling. It …